scholarly journals Management of hypertension in pregnancy – prevention, diagnosis, treatment and long-term prognosis

2019 ◽  
Author(s):  
Aleksander Prejbisz ◽  
Piotr Dobrowolski ◽  
Przemysław Kosiński ◽  
Dorota Bomba-Opoń ◽  
Marcin Adamczak ◽  
...  
2000 ◽  
Vol 19 (2) ◽  
pp. 199-209 ◽  
Author(s):  
Rafael Marín ◽  
Manuel Gorostidi ◽  
Carmen G. Portal ◽  
Marisa Sánchez ◽  
Emilio Sánchez ◽  
...  

Author(s):  
C.P. Lee ◽  
H.S. Wong ◽  
F.Y. Chan ◽  
T.C. Pun ◽  
W.K. To ◽  
...  

2012 ◽  
Vol 5 (2) ◽  
pp. 44-49 ◽  
Author(s):  
D Kernaghan ◽  
A C Duncan ◽  
G A McKay

Hypertensive disorders in pregnancy are common and can occur as a result of pre-existing hypertension or as new onset hypertension usually in the second half of pregnancy. In either situation there is potential for considerable perinatal and maternal morbidity and mortality. This review article aims to compare therapeutic options outlined in a selection of national guidelines and to look in more detail at the most commonly prescribed drugs – labetalol, methyldopa and nifedipine – with respect to their pharmacology and the evidence for their use in pregnancy. We will also consider the rationale for identifying and treating hypertension in pregnancy and the effect this can have on short- and long-term maternal and neonatal outcomes.


2012 ◽  
Vol 2012 ◽  
pp. 1-19 ◽  
Author(s):  
Reem Mustafa ◽  
Sana Ahmed ◽  
Anu Gupta ◽  
Rocco C. Venuto

Hypertension is the most common medical disorder encountered during pregnancy. Hypertensive disorders are one of the major causes of pregnancy-related maternal deaths in the United States. We will present a comprehensive update of the literature pertinent to hypertension in pregnancy. The paper begins by defining and classifying hypertensive disorders in pregnancy. The normal vascular and renal physiological changes which occur during pregnancy are detailed. We will summarize the intriguing aspects of pathophysiology of preeclampsia, emphasizing on recent advances in this field. The existing diagnostic tools and the tests which have been proposed for screening preeclampsia are comprehensively described. We also highlight the short- and long-term implications of preeclampsia. Finally, we review the current management guidelines, goals of treatment and describe the potential risks and benefits associated with various antihypertensive drug classes. Preeclampsia still remains an enigma, and the present management focuses on monitoring and treatment of its manifestations. We are hopeful that this in depth critique will stimulate the blossoming research in the field and assist practitioners to identify women at risk and more effectively treat affected individuals.


1988 ◽  
Vol 27 (1) ◽  
pp. 45-49 ◽  
Author(s):  
L. Selvaggi ◽  
G. Loverro ◽  
F.P. Schena ◽  
C. Manno ◽  
G. Cagnazzo

Author(s):  
Neha Khatod ◽  
Shubhra Mukharjee ◽  
Vijay Malviya

Hemolytic uremic syndrome (HUS) is characterized by triad of microangiopathic hemolytic anaemia, Thrombocytopenia and Acute renal failure. Genetically predisposed women develop HUS and may be triggered by pregnancy. The diagnosis is challenging due to overlapping clinical features of other diseases in pregnancy. The long-term prognosis is guarded. We are presenting a case of a young primigravida who underwent emergency lower (uterine) segment caesarean section (LSCS). She developed progressive anaemia, thrombocytopenia and renal failure postoperatively. Aggressive management with plasmapheresis, blood transfusions and hemodialysis saved her life. She is currently in remission.


2016 ◽  
Vol 214 (6) ◽  
pp. 722.e1-722.e6 ◽  
Author(s):  
Jane Tooher ◽  
Charlene Thornton ◽  
Angela Makris ◽  
Robert Ogle ◽  
Andrew Korda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document